Add Company
Join Now

Oblique Therapeutics Revenue and Competitors

License our Company Data API

Göteborg, Sweden

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Oblique Therapeutics's estimated annual revenue is currently $4.4M per year.(i)
  • Oblique Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Oblique Therapeutics has 22 Employees.(i)
  • Oblique Therapeutics grew their employee count by -21% last year.

Oblique Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.1M856%N/AN/A
#2
$51.1M2545%N/AN/A
#3
$24.7M1237%N/AN/A
#4
$86M4289%N/AN/A
#5
$1200M1330-6%$2.4BN/A
#6
$4.4M22-21%N/AN/A
#7
$9M4510%N/AN/A
#8
$28.5M1428%N/AN/A
#9
$8.8M4457%N/AN/A
#10
$7.6M3836%N/AN/A
Add Company

What Is Oblique Therapeutics?

Oblique Therapeutics is a privately held Swedish biotech, developing innovative new medicines for severe diseases with a large unmet medical need focusing on pain, and aggressive metastatic cancer. The company uses Abiprot an in house- invented next-generation antibody platform that can generate antibodies with programmed function against the full human proteome.. We make medicines that matter to patients.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$4.4M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Oblique Therapeutics News

2022-03-30 - Lumakras Drug Market Share Analysis 2022 Growth, Size Estimates, Global Revenues, Industry Trends & Upcoming

... Mirati Therapeutics Inc., Moderna Inc., Oblique Therapeutics AB, ... popularity of advanced therapies, are fuelling the market growth.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M23-15%N/A
#2
$2.3M2310%N/A
#3
$5.1M24-27%N/A
#4
$6M26-10%N/A
#5
$4.6M2613%N/A